2025年
1. Kawakita, T., T. Sekiya, Y. Kameda, N. Nomura, M. Ohno, C. Handabile, A. Yamaya, H. Fukuhara, Y. Anraku, S. Kita, S. Toba, H. Tsukamoto, T. Sawa, H. Oshiumi, K. Maenaka, A. Sato, H. Sawa, Y. Suzuki, L. E. Brown, D. C. Jackson, H. Kida, M. Matsumoto, T. Seya, and M. Shingai. 2025. ARNAX is a desirable adjuvant for a prophylactic vaccine against COVID-19 to enhance antigen-specific CD4+ and CD8+ T cell responses and neutralizing antibody induction. J Virol. (in press)
2. Sato,Y., A.Yamaya、K.Sonoda A. Wakita, Y. Nagaki, K. Kemuriyama, R.Sasamori, S. Nozaki, S. Takashima, K.Terata, K.Imai, M. Matsumoto, T. Seya, and Y. Minamiya. 2025. PolyI:C signaling induces robust CXCL10 production and apoptosis in human esophageal squamous cell carcinoma cells. Human Cell. (submitted).
2024年
1. Miyazaki, A., S. Yoshida, Y. Takeda, U. Tomaru, M. Matsumoto, T. Seya. 2024. Th1 adjuvant ARNAX, in combination with radiation therapy, enhances tumor regression in mouse tumor-implant models. Immunol Lett. 271:106947. doi: 10.1016/j.imlet.2024.106947.
2023年
1. Seya T. 2023. Innate-Acquired Linkage in Immunotherapy. Cells. 12(3): 371. doi: 10.3390/cells12030371.
2. Seya T, Shingai M, Kawakita T, Matsumoto M. 2023. Two Modes of Th1 Polarization Induced by Dendritic-Cell-Priming Adjuvant in Vaccination. Cells. 12(11): 1504. doi: 10.3390/cells12111504.
2022年
1.Seya, T., and M. Matsumoto. 2020. Seya, T., and M. Matsumoto. 2022. Toward developing harmless vaccines: ARNAX for prophylactic adjuvant. Cells.https://doi.org/10.3390/cells11244006
2.Iwata-Yoshikawa, N., N. Nagata, H. Takaki, M. Matsumoto, T. Suzuki, H. Hasegawa, T. Seya. 2022. Prophylactic vaccine targeting Toll-like receptor 3 (TLR3) on dendritic cells ameliorates eosinophilic pneumonia in a mouse SARS-CoV infection model. ImmunoHorizons. 6: 275-282 https://doi.org/10.4049/immunohorizons.2200020
2021年
1. Leong, C. R., T. Seya, T. W. Yenn, and W. N. Tan. 2021. Hepatitis B virus genomic nucleic acid in the activation and maturation of bone marrow-derived dendritic cells. AsPac J. Mol. Biol. Biotechnol. 29(4): 109-119.